Cargando…
Lung cancer screening: the way forward
To take lung cancer screening into national programmes, we first have to answer the question whether low-dose computed tomography (LDCT) screening and treatment of early lesions will decrease lung cancer mortality compared with a control group, to accurately estimate the balance of benefits and harm...
Autores principales: | Field, J K, Duffy, S W |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2527832/ https://www.ncbi.nlm.nih.gov/pubmed/18665179 http://dx.doi.org/10.1038/sj.bjc.6604509 |
Ejemplares similares
-
Food allergy in children—the current status and the way forward
por: Elghoudi, Ahmed, et al.
Publicado: (2022) -
Diabetes self-care in primary health facilities in India - challenges and the way forward
por: Basu, Saurav, et al.
Publicado: (2019) -
Lung cancer screening
por: Pastorino, U
Publicado: (2010) -
Renoprotection and the Bardoxolone Methyl Story – Is This the Right Way Forward? A Novel View of Renoprotection in CKD Trials: A New Classification Scheme for Renoprotective Agents
por: Onuigbo, Macaulay
Publicado: (2013) -
Lung cancer screening, what has changed after the latest evidence?
por: Trujillo-Reyes, Juan Carlos, et al.
Publicado: (2020)